CAR-T Trials Paused: Are All Cell Therapies the Same?
Key Takeaways Novartis paused eight autoimmune and nerve disease trials of its rap-cel CAR-T cell therapy on August 24, 2026. Three patients died from immune effector cell-associated hemophagocytic syndrome (IEC-HS). Bristol Myers Squibb had already paused its zola-cel autoimmune trials in early June after separate inflammatory reactions. No regulator has
September 9, 2026
1 Comment
